drugset / Trial / NCT00972907
An Open Label Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing in Human Subjects
NaSingle-groupOpen-labelTreatment
Summary
This is an open label study. The study will consist of 1 treatment group: coated Nifedipine suppository containing 12 mg of Nifedipine, administered BID to subjects with chronic anal fissure.
Timeline
- Start
- 2009-12
- Primary completion
- 2011-01
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nifedipine | Other / unclassified | 12 mg | Rectal |